公开(公告)号：US11118202B2

公开(公告)日：2021-09-14

申请号：US16084144

申请日：2017-03-31

Applicant: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION

Inventor： Kyoung Heon Kim ,  In-Geol Choi ,  Sora Yu ,  Eun-Ju Yun ,  Kyung-mun Cho

IPC: C12P19/02

Abstract: The present invention relates to a novel method for purifying 3,6-anhydro-L-galactose by using microorganisms and provides an effect of improving the production yield of 3,6-anhydro-L-galactose by using microorganisms during purification after enzymatic hydrolysis of agarose or agar.

公开(公告)号：US20220241349A1

公开(公告)日：2022-08-04

申请号：US17724386

申请日：2022-04-19

Applicant: Korea University Research and Business Foundation

Inventor： Kyoung Heon KIM ,  Yong-Su Jin ,  Eun-Ju Yun ,  Dong-Hyun Kim ,  Sora Yu ,  Kyung-mun Cho ,  Na Jeong Park

IPC: A61K35/74 ,  A23L33/125 ,  A23L33/135 ,  A23L33/00 ,  A61K35/745 ,  A61K47/26 ,  C12P19/00

Abstract: The present invention relates to a method for producing marine algae-derived agarotriose, and a use thereof as a prebiotic. More specifically, the present invention investigates the characteristics of agarotriose as a prebiotic which is selectively metabolized by probiotic microorganisms, thereby enabling agarotriose to be used as an anti-cancer or anti-inflammatory agent in the fields of food and pharmaceuticals, and enabling agarotriose to be obtained at high yield through efficient purification with minimal loss after enzymatic hydrolysis of a red algae-derived polysaccharide without pre-treatment.

公开(公告)号：US11337999B2

公开(公告)日：2022-05-24

申请号：US16764742

申请日：2018-11-15

Applicant: Korea University Research and Business Foundation

Inventor： Kyoung Heon Kim ,  Yong-Su Jin ,  Eun-Ju Yun ,  Dong-Hyun Kim ,  Sora Yu ,  Kyung-mun Cho ,  Na Jeong Park

IPC: A61K35/741 ,  A61K35/74 ,  A23L33/125 ,  A23L33/135 ,  A23L33/00 ,  A61K35/745 ,  A61K47/26 ,  C12P19/00 ,  A61K35/00

Abstract: The present invention relates to a method for producing marine algae-derived agarotriose, and a use thereof as a prebiotic. More specifically, the present invention investigates the characteristics of agarotriose as a prebiotic which is selectively metabolized by probiotic microorganisms, thereby enabling agarotriose to be used as an anti-cancer or anti-inflammatory agent in the fields of food and pharmaceuticals, and enabling agarotriose to be obtained at high yield through efficient purification with minimal loss after enzymatic hydrolysis of a red algae-derived polysaccharide without pre-treatment.